Main Session
Sep 29
EDU 46 - Perioperative Immunotherapy in Head and Neck Cancer: Trial Data, Real-World Practice and Radiation Oncology Implications

Perioperative Immunotherapy in Locally Advanced Surgically Resectable Head and Neck Cancer: Review of KEYNOTE 689 Data

02:17pm - 02:37pm ET
TBD

Presenter(s)

Robert Haddad, MD - Dana Farber Cancer Institute l, Boston, MA